Cellular and Molecular Biology of the Hepatic Stem Cell Compartment

肝干细胞室的细胞和分子生物学

基本信息

项目摘要

We have established an efficient system for differentiation, expansion and isolation of hepatic progenitor cells from mouse embryonic stem (ES) cells and evaluated their capacity to repopulate the diseased liver upon transplantation using a MUP-uPA/SCID mouse model of liver injury. The FACS-purified hepatic progenitorcells developed into mature hepatocytes without evidence of cell fusion and participated in rebuilding normal parenchyma with reconstitution of liver-specific zonal gradients of hepatic function. The ES cell-derived hepatocytes were responsive to normal growthregulation and proliferated at the same rate as the host hepatocytes after an additional growth stimulus from CCl4-induced liver injury. The transplanted cells also differentiated into biliary epithelial cells. These data demonstrate that a highly enriched population ofcommitted hepatocyte precursors can be generated from mouse ES cells in vitro for effective cell replacement therapy.In addition, we have now established a protocol for generating iPSCs from human fibroblasts by transduction with lentiviruses that independently expressed POU domain class 5 transcription factor 1 (OCT3/4) SRY-box containing gene 2, (SOX2),NANOG homeobox (NANOG), and Lin-28 homolog (LN28). These iPSCs recapitulate both the hepatocytic differentiation and morphological changes seen with the human ES cells. Recent studies suggested that induced pluripotent stem cells (iPSCs) retain a residual donor cell gene expression, which may impact their capacity to differentiate into cell of origin. We have recently addressed a contribution of a lineage stage-specific donor cell memory in modulating the functional properties of iPSCs. iPSCs were generated from hepatic lineage cells at an early (hepatoblast-derived, HB-iPSCs) and end stage (adult hepatocyte, AH-iPSCs) of hepatocyte differentiation as well as from mouse embryonic fibroblasts (MEFs-iPSCs) using a lentiviral vector encoding four pluripotency-inducing factors Oct4, Sox2, Klf4, and c-Myc. All resulting iPSC lines acquired iPSCs phenotype as judged by the accepted criteria including morphology, expression of pluripotency markers, silencing of transducing factors, capacity of multilineage differentiation in teratoma assay, and normal diploid karyotype. However, HB-iPSCs were more efficient in directed differentiation toward hepatocytic lineage as compared to AH-iPSCs, MEF-iPSCs, or mouse embryonic stem cells (mESCs). Extensive comparative transcriptome analyses of the early passage iPSCs, donor cells, and mESCs revealed that despite global similarities in gene expression patterns between generated iPSCs and mESCs, HB-iPSCs retained a transcriptional memory (seven upregulated and 17 downregulated genes) typical of the original cells. Continuous passaging of HB-iPSCs erased most of these differences including a superior capacity for hepatic redifferentiation. These results suggest that retention of lineage stage-specific donor memory in iPSCs may facilitate differentiation into donor cell type. The identified gene set may help to improve hepatic differentiation for therapeutic applications and contribute to the better understanding of liver development.
我们已经建立了一个有效的系统,从小鼠胚胎干细胞(ES)细胞分化,扩增和分离肝祖细胞,并评估其能力,重新移植后使用MUP-uPA/SCID小鼠模型的肝损伤的患病肝脏。流式细胞仪纯化的肝祖细胞发育为成熟的肝细胞,没有细胞融合的证据,并参与重建正常的肝实质,重建肝脏特异性的肝功能区域梯度。ES细胞衍生的肝细胞对正常的生长调节有反应,并且在CCl 4诱导的肝损伤的额外生长刺激后以与宿主肝细胞相同的速率增殖。移植的细胞还分化为胆管上皮细胞。此外,我们现在已经建立了一种通过用慢病毒转导从人成纤维细胞产生iPSC的方案,所述慢病毒独立地表达POU结构域5类转录因子1(OCT 3/4)SRY盒,所述SRY盒包含基因2(SOX 2),NANOG同源盒(NANOG),和Lin-28同系物(LN 28)。这些iPSC概括了人类ES细胞所见的肝细胞分化和形态学变化。最近的研究表明,诱导多能干细胞(iPSC)保留了残余的供体细胞基因表达,这可能会影响其分化为原始细胞的能力。我们最近已经解决了谱系阶段特异性供体细胞记忆在调节iPSC的功能特性中的贡献。使用编码四种多能诱导因子Oct 4、Sox 2、Klf 4和c-Myc的慢病毒载体,从肝细胞分化的早期(成肝细胞衍生的,HB-iPSC)和末期(成体肝细胞,AH-iPSC)的肝谱系细胞以及从小鼠胚胎成纤维细胞(MEFs-iPSC)产生iPSC。所有得到的iPSC系获得iPSC表型,如通过公认的标准判断的,所述标准包括形态学、多能性标志物的表达、转导因子的沉默、畸胎瘤测定中的多谱系分化能力和正常二倍体核型。然而,与AH-iPSC、MEF-iPSC或小鼠胚胎干细胞(mESC)相比,HB-iPSC在向肝细胞谱系定向分化方面更有效。对早期传代iPSC、供体细胞和mESC的广泛比较转录组分析显示,尽管所产生的iPSC和mESC之间的基因表达模式具有全局相似性,但HB-iPSC保留了原始细胞典型的转录记忆(7个上调和17个下调基因)。HB-iPSC的连续传代消除了大部分这些差异,包括肝再分化的上级能力。这些结果表明,iPSC中谱系阶段特异性供体记忆的保留可以促进分化为供体细胞类型。鉴定的基因集可能有助于改善肝分化的治疗应用,并有助于更好地了解肝脏发育。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Contribution of hepatic lineage stage-specific donor memory to the differential potential of induced mouse pluripotent stem cells.
  • DOI:
    10.1002/stem.1074
  • 发表时间:
    2012-05
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    Lee, Seung Bum;Seo, Daekwan;Choi, Dongho;Park, Kye-Yoon;Holczbauer, Agnes;Marquardt, Jens U.;Conner, Elizabeth A.;Factor, Valentina M.;Thorgeirsson, Snorri S.
  • 通讯作者:
    Thorgeirsson, Snorri S.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Snorri Thorgeirsson其他文献

Snorri Thorgeirsson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Snorri Thorgeirsson', 18)}}的其他基金

Cancer stem cells and human liver cancer
癌症干细胞与人类肝癌
  • 批准号:
    8937929
  • 财政年份:
  • 资助金额:
    $ 12.72万
  • 项目类别:
Cancer stem cells and human liver cancer
癌症干细胞与人类肝癌
  • 批准号:
    8349290
  • 财政年份:
  • 资助金额:
    $ 12.72万
  • 项目类别:
The role of c-met in liver biology
c-met 在肝脏生物学中的作用
  • 批准号:
    7965490
  • 财政年份:
  • 资助金额:
    $ 12.72万
  • 项目类别:
Comparative Functional Genomics
比较功能基因组学
  • 批准号:
    7966157
  • 财政年份:
  • 资助金额:
    $ 12.72万
  • 项目类别:
Cancer stem cells and human liver cancer
癌症干细胞与人类肝癌
  • 批准号:
    7965969
  • 财政年份:
  • 资助金额:
    $ 12.72万
  • 项目类别:
Cellular and Molecular Biology of the Hepatic Stem Cell Compartment
肝干细胞室的细胞和分子生物学
  • 批准号:
    7965036
  • 财政年份:
  • 资助金额:
    $ 12.72万
  • 项目类别:
The role of c-met in liver biology
c-met 在肝脏生物学中的作用
  • 批准号:
    8349082
  • 财政年份:
  • 资助金额:
    $ 12.72万
  • 项目类别:
Cancer stem cells and human liver cancer
癌症干细胞与人类肝癌
  • 批准号:
    8552944
  • 财政年份:
  • 资助金额:
    $ 12.72万
  • 项目类别:
The role of c-met in liver biology
c-met 在肝脏生物学中的作用
  • 批准号:
    8552759
  • 财政年份:
  • 资助金额:
    $ 12.72万
  • 项目类别:
Validation of Therapeutic Target Genes in Human Liver Cancer
人类肝癌治疗靶基因的验证
  • 批准号:
    8937992
  • 财政年份:
  • 资助金额:
    $ 12.72万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 12.72万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.72万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 12.72万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.72万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 12.72万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 12.72万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.72万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 12.72万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 12.72万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.72万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了